

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * thyroid gland development (GO:0030878) | 8.33583193 |
| 2 | sulfate transmembrane transport (GO:1902358) | 7.24839224 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 6.53258628 |
| 4 | viral transcription (GO:0019083) | 6.07282020 |
| 5 | sulfate transport (GO:0008272) | 6.03957110 |
| 6 | translational termination (GO:0006415) | 5.80416670 |
| 7 | DNA deamination (GO:0045006) | 5.64889402 |
| 8 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.48898339 |
| 9 | ribosomal small subunit biogenesis (GO:0042274) | 5.43588268 |
| 10 | cotranslational protein targeting to membrane (GO:0006613) | 5.40142433 |
| 11 | protein targeting to ER (GO:0045047) | 5.35559103 |
| 12 | excretion (GO:0007588) | 5.18339714 |
| 13 | protein localization to endoplasmic reticulum (GO:0070972) | 5.10657485 |
| 14 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.08081582 |
| 15 | GDP-mannose metabolic process (GO:0019673) | 5.07056899 |
| 16 | lymphoid progenitor cell differentiation (GO:0002320) | 5.03509386 |
| 17 | response to mercury ion (GO:0046689) | 5.01919487 |
| 18 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.87258720 |
| 19 | translational elongation (GO:0006414) | 4.83829808 |
| 20 | * regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.82027763 |
| 21 | respiratory chain complex IV assembly (GO:0008535) | 4.70657850 |
| 22 | * metanephric nephron tubule development (GO:0072234) | 4.65125512 |
| 23 | * metanephric tubule development (GO:0072170) | 4.65125512 |
| 24 | * metanephric nephron epithelium development (GO:0072243) | 4.57481799 |
| 25 | generation of neurons (GO:0048699) | 4.51750403 |
| 26 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.50130299 |
| 27 | viral life cycle (GO:0019058) | 4.45153321 |
| 28 | * metanephric epithelium development (GO:0072207) | 4.36317315 |
| 29 | actin filament depolymerization (GO:0030042) | 4.33999394 |
| 30 | mannosylation (GO:0097502) | 4.33225258 |
| 31 | peptidyl-threonine dephosphorylation (GO:0035970) | 4.29004594 |
| 32 | maturation of SSU-rRNA (GO:0030490) | 4.25221381 |
| 33 | cellular protein complex disassembly (GO:0043624) | 4.24396292 |
| 34 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.18738931 |
| 35 | platelet dense granule organization (GO:0060155) | 4.14787860 |
| 36 | facial nerve structural organization (GO:0021612) | 4.13076852 |
| 37 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 4.12716598 |
| 38 | collecting duct development (GO:0072044) | 4.12348291 |
| 39 | * regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 4.10708062 |
| 40 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.01777722 |
| 41 | translational initiation (GO:0006413) | 3.97763920 |
| 42 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 3.96533214 |
| 43 | response to interferon-alpha (GO:0035455) | 3.96521838 |
| 44 | GPI anchor biosynthetic process (GO:0006506) | 3.94702359 |
| 45 | cardiovascular system development (GO:0072358) | 3.92396734 |
| 46 | positive regulation of p38MAPK cascade (GO:1900745) | 3.88920191 |
| 47 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.88470455 |
| 48 | L-fucose catabolic process (GO:0042355) | 3.87080952 |
| 49 | fucose catabolic process (GO:0019317) | 3.87080952 |
| 50 | L-fucose metabolic process (GO:0042354) | 3.87080952 |
| 51 | postsynaptic membrane organization (GO:0001941) | 3.84552280 |
| 52 | * negative regulation of metanephros development (GO:0072217) | 3.82991953 |
| 53 | polyol transport (GO:0015791) | 3.80536903 |
| 54 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.73617846 |
| 55 | phosphate ion transport (GO:0006817) | 3.73109857 |
| 56 | signal peptide processing (GO:0006465) | 3.72641961 |
| 57 | ribosomal large subunit biogenesis (GO:0042273) | 3.71075482 |
| 58 | barbed-end actin filament capping (GO:0051016) | 3.67938580 |
| 59 | telomere maintenance via recombination (GO:0000722) | 3.67853788 |
| 60 | protein complex disassembly (GO:0043241) | 3.67804285 |
| 61 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.65568425 |
| 62 | cytochrome complex assembly (GO:0017004) | 3.61456898 |
| 63 | C-terminal protein lipidation (GO:0006501) | 3.58751350 |
| 64 | hydrogen peroxide catabolic process (GO:0042744) | 3.58259817 |
| 65 | response to water (GO:0009415) | 3.55231047 |
| 66 | proteasome assembly (GO:0043248) | 3.54909085 |
| 67 | positive regulation of protein export from nucleus (GO:0046827) | 3.50081129 |
| 68 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.47955461 |
| 69 | macromolecular complex disassembly (GO:0032984) | 3.46758725 |
| 70 | * negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 3.45768020 |
| 71 | cranial nerve morphogenesis (GO:0021602) | 3.43340279 |
| 72 | protein targeting to membrane (GO:0006612) | 3.41801824 |
| 73 | DNA replication initiation (GO:0006270) | 3.40426705 |
| 74 | * regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.34692024 |
| 75 | response to interferon-beta (GO:0035456) | 3.34001936 |
| 76 | definitive hemopoiesis (GO:0060216) | 3.32974271 |
| 77 | hormone biosynthetic process (GO:0042446) | 3.32683149 |
| 78 | DNA strand elongation (GO:0022616) | 3.32059443 |
| 79 | negative regulation of fatty acid transport (GO:2000192) | 3.29307368 |
| 80 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.29119240 |
| 81 | * nephron tubule development (GO:0072080) | 3.28095118 |
| 82 | * nephron tubule formation (GO:0072079) | 3.26104751 |
| 83 | regulation of water loss via skin (GO:0033561) | 3.25575158 |
| 84 | mitotic recombination (GO:0006312) | 3.22744357 |
| 85 | translation (GO:0006412) | 3.22582622 |
| 86 | pseudouridine synthesis (GO:0001522) | 3.22263445 |
| 87 | regulation of p38MAPK cascade (GO:1900744) | 3.20712600 |
| 88 | GPI anchor metabolic process (GO:0006505) | 3.17602215 |
| 89 | cell volume homeostasis (GO:0006884) | 3.16065830 |
| 90 | sulfur compound transport (GO:0072348) | 3.14247274 |
| 91 | genitalia morphogenesis (GO:0035112) | 3.14126345 |
| 92 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 3.13947878 |
| 93 | phospholipid scrambling (GO:0017121) | 3.12949304 |
| 94 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.11775511 |
| 95 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.11711016 |
| 96 | mature B cell differentiation involved in immune response (GO:0002313) | 3.11232500 |
| 97 | regulation of pigment cell differentiation (GO:0050932) | 3.10523120 |
| 98 | endothelial cell chemotaxis (GO:0035767) | 3.08935080 |
| 99 | phenol-containing compound metabolic process (GO:0018958) | 3.08074242 |
| 100 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.06967219 |
| 101 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.04827560 |
| 102 | peptide catabolic process (GO:0043171) | 3.04106188 |
| 103 | phosphate ion transmembrane transport (GO:0035435) | 3.03884446 |
| 104 | regulation of myelination (GO:0031641) | 3.02267999 |
| 105 | * renal tubule development (GO:0061326) | 3.02188722 |
| 106 | cranial nerve structural organization (GO:0021604) | 3.01058311 |
| 107 | thyroid hormone generation (GO:0006590) | 20.5358160 |
| 108 | mRNA catabolic process (GO:0006402) | 2.99968772 |
| 109 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.98667364 |
| 110 | endosome to pigment granule transport (GO:0043485) | 2.98003084 |
| 111 | endosome to melanosome transport (GO:0035646) | 2.98003084 |
| 112 | mesodermal cell differentiation (GO:0048333) | 2.97356663 |
| 113 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.96309002 |
| 114 | lung vasculature development (GO:0060426) | 2.92606881 |
| 115 | mast cell activation (GO:0045576) | 2.92402746 |
| 116 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.91748364 |
| 117 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.91248151 |
| 118 | positive regulation of gluconeogenesis (GO:0045722) | 2.90574681 |
| 119 | telomere maintenance via telomere lengthening (GO:0010833) | 2.89567544 |
| 120 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.88353034 |
| 121 | regulation of hippo signaling (GO:0035330) | 2.87593044 |
| 122 | endothelial cell morphogenesis (GO:0001886) | 2.86907183 |
| 123 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.85659305 |
| 124 | termination of RNA polymerase III transcription (GO:0006386) | 2.85659305 |
| 125 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.84007107 |
| 126 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.84007107 |
| 127 | C-terminal protein amino acid modification (GO:0018410) | 2.83599306 |
| 128 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.83223375 |
| 129 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.82491606 |
| 130 | NADH dehydrogenase complex assembly (GO:0010257) | 2.82491606 |
| 131 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.82491606 |
| 132 | RNA catabolic process (GO:0006401) | 2.81575457 |
| 133 | positive regulation of vesicle fusion (GO:0031340) | 2.80061746 |
| 134 | * nephron epithelium development (GO:0072009) | 2.78960842 |
| 135 | angiogenesis involved in wound healing (GO:0060055) | 2.78772792 |
| 136 | urate metabolic process (GO:0046415) | 2.78427866 |
| 137 | * regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.77428305 |
| 138 | positive regulation of digestive system process (GO:0060456) | 2.75511091 |
| 139 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.75037686 |
| 140 | mature B cell differentiation (GO:0002335) | 2.74952477 |
| 141 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.74642279 |
| 142 | regulation of metalloenzyme activity (GO:0048552) | 2.72969210 |
| 143 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.72085377 |
| 144 | multicellular organismal water homeostasis (GO:0050891) | 2.66773455 |
| 145 | lymph node development (GO:0048535) | 2.66645599 |
| 146 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.64741877 |
| 147 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.63240244 |
| 148 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.62828008 |
| 149 | endothelium development (GO:0003158) | 2.62758677 |
| 150 | cell differentiation involved in metanephros development (GO:0072202) | 2.62042120 |
| 151 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.62031297 |
| 152 | response to thyroid hormone (GO:0097066) | 2.61832671 |
| 153 | fucosylation (GO:0036065) | 2.61362246 |
| 154 | sexual reproduction (GO:0019953) | 2.61211644 |
| 155 | inorganic anion transport (GO:0015698) | 2.60371034 |
| 156 | DNA ligation (GO:0006266) | 2.59888073 |
| 157 | membrane repolarization during action potential (GO:0086011) | 2.59473067 |
| 158 | cellular component biogenesis (GO:0044085) | 2.59414432 |
| 159 | regulation of developmental pigmentation (GO:0048070) | 2.58938997 |
| 160 | regulation of protein localization to cell surface (GO:2000008) | 2.58631351 |
| 161 | defense response to protozoan (GO:0042832) | 2.58421301 |
| 162 | establishment of endothelial barrier (GO:0061028) | 2.57380935 |
| 163 | GTP biosynthetic process (GO:0006183) | 2.56909543 |
| 164 | cell-cell junction maintenance (GO:0045217) | 2.55659181 |
| 165 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.55557294 |
| 166 | * regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 2.55081733 |
| 167 | hemidesmosome assembly (GO:0031581) | 2.55045236 |
| 168 | desmosome organization (GO:0002934) | 2.53374311 |
| 169 | water homeostasis (GO:0030104) | 2.52990580 |
| 170 | regulation of Rap GTPase activity (GO:0032317) | 2.51488076 |
| 171 | skin morphogenesis (GO:0043589) | 2.51193915 |
| 172 | * negative regulation of kidney development (GO:0090185) | 2.50041819 |
| 173 | endocrine hormone secretion (GO:0060986) | 2.48632336 |
| 174 | membrane raft organization (GO:0031579) | 2.47351035 |
| 175 | negative regulation of lipid storage (GO:0010888) | 2.46886918 |
| 176 | cell adhesion mediated by integrin (GO:0033627) | 2.46868267 |
| 177 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.45938285 |
| 178 | * regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.45887360 |
| 179 | positive regulation of glomerulus development (GO:0090193) | 2.45706159 |
| 180 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.44797733 |
| 181 | glomerular basement membrane development (GO:0032836) | 2.44038289 |
| 182 | * cellular response to gonadotropin stimulus (GO:0071371) | 2.44031231 |
| 183 | mammary gland alveolus development (GO:0060749) | 2.43473559 |
| 184 | sodium-independent organic anion transport (GO:0043252) | 2.42513725 |
| 185 | establishment of skin barrier (GO:0061436) | 2.41666460 |
| 186 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.39580113 |
| 187 | * mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.39275415 |
| 188 | negative regulation of hormone metabolic process (GO:0032351) | 2.38896319 |
| 189 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.38380033 |
| 190 | bone remodeling (GO:0046849) | 2.38275962 |
| 191 | positive regulation of astrocyte differentiation (GO:0048711) | 2.36403522 |
| 192 | hydrogen peroxide metabolic process (GO:0042743) | 2.36249970 |
| 193 | regulation of lipoprotein metabolic process (GO:0050746) | 2.34295617 |
| 194 | positive regulation of osteoblast proliferation (GO:0033690) | 2.33839994 |
| 195 | quaternary ammonium group transport (GO:0015697) | 2.31025416 |
| 196 | positive regulation of Rap GTPase activity (GO:0032854) | 2.30037720 |
| 197 | mRNA transcription (GO:0009299) | 2.29835378 |
| 198 | glutathione biosynthetic process (GO:0006750) | 2.29228957 |
| 199 | glomerular visceral epithelial cell development (GO:0072015) | 2.28554995 |
| 200 | thyroid hormone metabolic process (GO:0042403) | 16.5405033 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.40556049 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.95135426 |
| 3 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.59484435 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.49697484 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.47130628 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.46440154 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.41200189 |
| 8 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.40426881 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.38917901 |
| 10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.36008946 |
| 11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.31058872 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.26132990 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.21801598 |
| 14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.16321569 |
| 15 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 3.07522428 |
| 16 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.04745550 |
| 17 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.97854255 |
| 18 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.90268245 |
| 19 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.82104975 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.81525776 |
| 21 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.77836377 |
| 22 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.73723329 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.72525666 |
| 24 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.70396829 |
| 25 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.65622767 |
| 26 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.58156877 |
| 27 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.57367872 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.55867572 |
| 29 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.53255537 |
| 30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.51450601 |
| 31 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.51141398 |
| 32 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.50228512 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 2.42062082 |
| 34 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.41647009 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.41445578 |
| 36 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.31950471 |
| 37 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.26540847 |
| 38 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.16255186 |
| 39 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.13049968 |
| 40 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.10750278 |
| 41 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.08951620 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.05810731 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.03409671 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.01884772 |
| 45 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.00184773 |
| 46 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.95652693 |
| 47 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.94044765 |
| 48 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.93819846 |
| 49 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93702738 |
| 50 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.91944710 |
| 51 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.89874656 |
| 52 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.89339367 |
| 53 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.89297772 |
| 54 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.86634964 |
| 55 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.86297898 |
| 56 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.84901018 |
| 57 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.84842322 |
| 58 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.83414287 |
| 59 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.80632366 |
| 60 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.79055673 |
| 61 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.76604211 |
| 62 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.76460710 |
| 63 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.72050392 |
| 64 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.71447224 |
| 65 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.70319008 |
| 66 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.70301259 |
| 67 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.70147515 |
| 68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.69330538 |
| 69 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.68274313 |
| 70 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.67896610 |
| 71 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.66717056 |
| 72 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.66439108 |
| 73 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.66174632 |
| 74 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.65293920 |
| 75 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.63144714 |
| 76 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.63011169 |
| 77 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.59474875 |
| 78 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.59069396 |
| 79 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57051686 |
| 80 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.54573194 |
| 81 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.54563807 |
| 82 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.54563807 |
| 83 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.54286928 |
| 84 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.52151932 |
| 85 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.50287428 |
| 86 | CJUN_26792858_Chip-Seq_BT549_Human | 1.48900987 |
| 87 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.48572013 |
| 88 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.48153014 |
| 89 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.46939412 |
| 90 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.46927017 |
| 91 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.46295946 |
| 92 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.46244478 |
| 93 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.46105587 |
| 94 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.45972991 |
| 95 | TP53_16413492_ChIP-PET_HCT116_Human | 1.45869082 |
| 96 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.45714165 |
| 97 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.44922287 |
| 98 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.43193277 |
| 99 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.42049495 |
| 100 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.41599849 |
| 101 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.40975905 |
| 102 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.39966067 |
| 103 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.39708202 |
| 104 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38621909 |
| 105 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.36458755 |
| 106 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.36219686 |
| 107 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34304831 |
| 108 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.33737835 |
| 109 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.33737835 |
| 110 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33599378 |
| 111 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.33345959 |
| 112 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.32202384 |
| 113 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.31265663 |
| 114 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.30322001 |
| 115 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.29754025 |
| 116 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.29639285 |
| 117 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.25159895 |
| 118 | MYB_26560356_Chip-Seq_TH2_Human | 1.24485933 |
| 119 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23038101 |
| 120 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.22948577 |
| 121 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.22581858 |
| 122 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22279239 |
| 123 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.22073195 |
| 124 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.21816772 |
| 125 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.21700591 |
| 126 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.21077374 |
| 127 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.21020984 |
| 128 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.19439625 |
| 129 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18558018 |
| 130 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18228757 |
| 131 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.17550549 |
| 132 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.17410212 |
| 133 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.17280737 |
| 134 | KDM2B_26808549_Chip-Seq_K562_Human | 1.17036442 |
| 135 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.16839729 |
| 136 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.16422726 |
| 137 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.15287969 |
| 138 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.15098754 |
| 139 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.15017945 |
| 140 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14787561 |
| 141 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.14678084 |
| 142 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.14264922 |
| 143 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13802565 |
| 144 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.13794967 |
| 145 | ATF3_27146783_Chip-Seq_COLON_Human | 1.12298951 |
| 146 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12208290 |
| 147 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10767883 |
| 148 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.08948873 |
| 149 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07984391 |
| 150 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.07732004 |
| 151 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.06833217 |
| 152 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.05874943 |
| 153 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05497874 |
| 154 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.05244935 |
| 155 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04312664 |
| 156 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.04201536 |
| 157 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.03007828 |
| 158 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.01646806 |
| 159 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.00822650 |
| 160 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.99243292 |
| 161 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.98537245 |
| 162 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.97221874 |
| 163 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.96700339 |
| 164 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96215483 |
| 165 | MAF_26560356_Chip-Seq_TH1_Human | 0.96139991 |
| 166 | * MYB_26560356_Chip-Seq_TH1_Human | 0.94656843 |
| 167 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.94465940 |
| 168 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.94245152 |
| 169 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.92985614 |
| 170 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.90649741 |
| 171 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.90448801 |
| 172 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.90161825 |
| 173 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90160523 |
| 174 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89990401 |
| 175 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.88709519 |
| 176 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87054267 |
| 177 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.86909260 |
| 178 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.85367785 |
| 179 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.85366244 |
| 180 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.85246536 |
| 181 | MYC_22102868_ChIP-Seq_BL_Human | 0.83625071 |
| 182 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82880020 |
| 183 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.82659605 |
| 184 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.82495138 |
| 185 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.82426463 |
| 186 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.82176314 |
| 187 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.81743169 |
| 188 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.80445177 |
| 189 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.80386327 |
| 190 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.79663157 |
| 191 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.79266879 |
| 192 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.78393445 |
| 193 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.77802127 |
| 194 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.77338889 |
| 195 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.77173306 |
| 196 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76899460 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 6.37127641 |
| 2 | MP0009379_abnormal_foot_pigmentation | 5.68951086 |
| 3 | MP0005174_abnormal_tail_pigmentation | 4.08882277 |
| 4 | MP0005409_darkened_coat_color | 3.85775604 |
| 5 | MP0001188_hyperpigmentation | 3.73726035 |
| 6 | MP0003195_calcinosis | 3.49436059 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 3.42915596 |
| 8 | MP0000383_abnormal_hair_follicle | 3.32268240 |
| 9 | MP0001756_abnormal_urination | 3.29625006 |
| 10 | MP0006292_abnormal_olfactory_placode | 3.01042573 |
| 11 | MP0002396_abnormal_hematopoietic_system | 3.00395910 |
| 12 | MP0005075_abnormal_melanosome_morpholog | 2.94582364 |
| 13 | MP0010678_abnormal_skin_adnexa | 2.92377876 |
| 14 | MP0008004_abnormal_stomach_pH | 2.80076649 |
| 15 | MP0000490_abnormal_crypts_of | 2.75814793 |
| 16 | MP0003724_increased_susceptibility_to | 2.71600292 |
| 17 | MP0010368_abnormal_lymphatic_system | 2.63165912 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.56347291 |
| 19 | MP0004147_increased_porphyrin_level | 2.53946825 |
| 20 | MP0009785_altered_susceptibility_to | 2.53120805 |
| 21 | MP0000015_abnormal_ear_pigmentation | 2.47924883 |
| 22 | MP0003136_yellow_coat_color | 2.45794152 |
| 23 | MP0010386_abnormal_urinary_bladder | 2.44273800 |
| 24 | MP0001835_abnormal_antigen_presentation | 2.43260127 |
| 25 | MP0009643_abnormal_urine_homeostasis | 2.32560234 |
| 26 | MP0005671_abnormal_response_to | 2.30904318 |
| 27 | MP0004019_abnormal_vitamin_homeostasis | 2.28393103 |
| 28 | MP0003868_abnormal_feces_composition | 2.22511948 |
| 29 | MP0002095_abnormal_skin_pigmentation | 2.21222500 |
| 30 | MP0003300_gastrointestinal_ulcer | 2.18969975 |
| 31 | MP0001765_abnormal_ion_homeostasis | 2.17776223 |
| 32 | MP0000685_abnormal_immune_system | 2.13789315 |
| 33 | MP0003566_abnormal_cell_adhesion | 2.10586388 |
| 34 | MP0004381_abnormal_hair_follicle | 2.07965372 |
| 35 | MP0003646_muscle_fatigue | 2.00939706 |
| 36 | MP0002877_abnormal_melanocyte_morpholog | 1.99323670 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.99192881 |
| 38 | MP0004272_abnormal_basement_membrane | 1.98494584 |
| 39 | MP0005023_abnormal_wound_healing | 1.95357060 |
| 40 | MP0001986_abnormal_taste_sensitivity | 1.94466886 |
| 41 | MP0002168_other_aberrant_phenotype | 1.91065952 |
| 42 | MP0005025_abnormal_response_to | 1.89200132 |
| 43 | MP0003763_abnormal_thymus_physiology | 1.87293124 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.87173032 |
| 45 | MP0000534_abnormal_ureter_morphology | 1.85536307 |
| 46 | MP0002928_abnormal_bile_duct | 1.85097233 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.84606499 |
| 48 | MP0002136_abnormal_kidney_physiology | 1.81091694 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.80276860 |
| 50 | MP0002876_abnormal_thyroid_physiology | 1.78574490 |
| 51 | MP0004885_abnormal_endolymph | 1.74856138 |
| 52 | MP0000372_irregular_coat_pigmentation | 1.74510945 |
| 53 | MP0003045_fibrosis | 1.71143621 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.65496539 |
| 55 | MP0002254_reproductive_system_inflammat | 1.64634862 |
| 56 | MP0005000_abnormal_immune_tolerance | 1.60379065 |
| 57 | MP0001545_abnormal_hematopoietic_system | 1.56110482 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.56110482 |
| 59 | MP0003252_abnormal_bile_duct | 1.50623824 |
| 60 | MP0003436_decreased_susceptibility_to | 1.48140626 |
| 61 | MP0010155_abnormal_intestine_physiology | 1.47731084 |
| 62 | MP0002398_abnormal_bone_marrow | 1.47484276 |
| 63 | MP0002723_abnormal_immune_serum | 1.46321462 |
| 64 | MP0008007_abnormal_cellular_replicative | 1.46083524 |
| 65 | MP0002420_abnormal_adaptive_immunity | 1.45874837 |
| 66 | MP0005076_abnormal_cell_differentiation | 1.44358109 |
| 67 | MP0001819_abnormal_immune_cell | 1.43927320 |
| 68 | * MP0000681_abnormal_thyroid_gland | 1.41433106 |
| 69 | MP0001853_heart_inflammation | 1.40399242 |
| 70 | MP0001800_abnormal_humoral_immune | 1.39892152 |
| 71 | MP0002419_abnormal_innate_immunity | 1.38279116 |
| 72 | MP0004264_abnormal_extraembryonic_tissu | 1.37647940 |
| 73 | MP0001873_stomach_inflammation | 1.37003190 |
| 74 | MP0000689_abnormal_spleen_morphology | 1.36804294 |
| 75 | MP0008058_abnormal_DNA_repair | 1.36613407 |
| 76 | MP0003866_abnormal_defecation | 1.34609040 |
| 77 | MP0002452_abnormal_antigen_presenting | 1.34592362 |
| 78 | MP0003880_abnormal_central_pattern | 1.34222752 |
| 79 | MP0004808_abnormal_hematopoietic_stem | 1.33711896 |
| 80 | MP0003091_abnormal_cell_migration | 1.32359509 |
| 81 | MP0000716_abnormal_immune_system | 1.30559010 |
| 82 | MP0002722_abnormal_immune_system | 1.25430901 |
| 83 | MP0001502_abnormal_circadian_rhythm | 1.25429652 |
| 84 | MP0000678_abnormal_parathyroid_gland | 1.24595998 |
| 85 | MP0005464_abnormal_platelet_physiology | 1.23421882 |
| 86 | MP0003693_abnormal_embryo_hatching | 1.23206294 |
| 87 | MP0002429_abnormal_blood_cell | 1.19644463 |
| 88 | MP0003453_abnormal_keratinocyte_physiol | 1.18938973 |
| 89 | MP0001958_emphysema | 1.18552140 |
| 90 | MP0002638_abnormal_pupillary_reflex | 1.15939158 |
| 91 | MP0004510_myositis | 1.15316044 |
| 92 | MP0002166_altered_tumor_susceptibility | 1.13072095 |
| 93 | MP0008260_abnormal_autophagy | 1.12015443 |
| 94 | MP0002938_white_spotting | 1.09441072 |
| 95 | MP0005084_abnormal_gallbladder_morpholo | 1.09331159 |
| 96 | MP0005332_abnormal_amino_acid | 1.08559287 |
| 97 | MP0006054_spinal_hemorrhage | 1.07402576 |
| 98 | MP0001663_abnormal_digestive_system | 1.06896713 |
| 99 | MP0003950_abnormal_plasma_membrane | 1.06804574 |
| 100 | MP0001485_abnormal_pinna_reflex | 1.05211984 |
| 101 | MP0001270_distended_abdomen | 1.04236609 |
| 102 | MP0006036_abnormal_mitochondrial_physio | 1.04081140 |
| 103 | MP0001845_abnormal_inflammatory_respons | 1.02651634 |
| 104 | MP0002132_abnormal_respiratory_system | 1.02566828 |
| 105 | MP0005360_urolithiasis | 1.01989295 |
| 106 | MP0005387_immune_system_phenotype | 0.98888576 |
| 107 | MP0001790_abnormal_immune_system | 0.98888576 |
| 108 | MP0008961_abnormal_basal_metabolism | 0.97480532 |
| 109 | MP0002998_abnormal_bone_remodeling | 0.97400696 |
| 110 | MP0000003_abnormal_adipose_tissue | 0.96600687 |
| 111 | MP0002006_tumorigenesis | 0.95322401 |
| 112 | MP0008469_abnormal_protein_level | 0.94833855 |
| 113 | MP0003959_abnormal_lean_body | 0.94465243 |
| 114 | MP0005375_adipose_tissue_phenotype | 0.93370879 |
| 115 | MP0003786_premature_aging | 0.91027268 |
| 116 | MP0005636_abnormal_mineral_homeostasis | 0.90210527 |
| 117 | MP0010094_abnormal_chromosome_stability | 0.88527376 |
| 118 | MP0002933_joint_inflammation | 0.88462619 |
| 119 | MP0001879_abnormal_lymphatic_vessel | 0.88376253 |
| 120 | MP0002135_abnormal_kidney_morphology | 0.87256341 |
| 121 | MP0002751_abnormal_autonomic_nervous | 0.84799229 |
| 122 | MP0000477_abnormal_intestine_morphology | 0.83604837 |
| 123 | MP0003828_pulmonary_edema | 0.83331412 |
| 124 | MP0004185_abnormal_adipocyte_glucose | 0.83076128 |
| 125 | MP0001881_abnormal_mammary_gland | 0.82972974 |
| 126 | MP0002139_abnormal_hepatobiliary_system | 0.82456841 |
| 127 | MP0000538_abnormal_urinary_bladder | 0.82169240 |
| 128 | MP0002405_respiratory_system_inflammati | 0.81045711 |
| 129 | MP0002102_abnormal_ear_morphology | 0.79730454 |
| 130 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79436281 |
| 131 | MP0000537_abnormal_urethra_morphology | 0.78690212 |
| 132 | MP0000703_abnormal_thymus_morphology | 0.78235365 |
| 133 | MP0000613_abnormal_salivary_gland | 0.77637904 |
| 134 | MP0005395_other_phenotype | 0.77158955 |
| 135 | MP0000013_abnormal_adipose_tissue | 0.77113893 |
| 136 | MP0002796_impaired_skin_barrier | 0.76609923 |
| 137 | MP0004947_skin_inflammation | 0.76604055 |
| 138 | MP0002019_abnormal_tumor_incidence | 0.76244674 |
| 139 | MP0002249_abnormal_larynx_morphology | 0.76223854 |
| 140 | MP0004742_abnormal_vestibular_system | 0.76147302 |
| 141 | MP0002075_abnormal_coat/hair_pigmentati | 0.75728758 |
| 142 | MP0004858_abnormal_nervous_system | 0.75522441 |
| 143 | MP0003656_abnormal_erythrocyte_physiolo | 0.75247884 |
| 144 | MP0005666_abnormal_adipose_tissue | 0.74497181 |
| 145 | MP0000762_abnormal_tongue_morphology | 0.73896931 |
| 146 | MP0008057_abnormal_DNA_replication | 0.73483930 |
| 147 | MP0003186_abnormal_redox_activity | 0.72418707 |
| 148 | MP0009840_abnormal_foam_cell | 0.72409612 |
| 149 | MP0002896_abnormal_bone_mineralization | 0.72375834 |
| 150 | MP0009764_decreased_sensitivity_to | 0.72282159 |
| 151 | MP0000343_altered_response_to | 0.72071734 |
| 152 | MP0003705_abnormal_hypodermis_morpholog | 0.70615646 |
| 153 | * MP0002177_abnormal_outer_ear | 0.70501390 |
| 154 | MP0004957_abnormal_blastocyst_morpholog | 0.69048935 |
| 155 | MP0003315_abnormal_perineum_morphology | 0.68804225 |
| 156 | MP0000470_abnormal_stomach_morphology | 0.67852190 |
| 157 | MP0009780_abnormal_chondrocyte_physiolo | 0.66793616 |
| 158 | MP0003303_peritoneal_inflammation | 0.66315698 |
| 159 | MP0010771_integument_phenotype | 0.65709714 |
| 160 | MP0001851_eye_inflammation | 0.65650479 |
| 161 | MP0005381_digestive/alimentary_phenotyp | 0.65333268 |
| 162 | MP0003191_abnormal_cellular_cholesterol | 0.64311654 |
| 163 | MP0000858_altered_metastatic_potential | 0.64175422 |
| 164 | MP0005164_abnormal_response_to | 0.64024000 |
| 165 | MP0003942_abnormal_urinary_system | 0.62667394 |
| 166 | MP0004084_abnormal_cardiac_muscle | 0.62236667 |
| 167 | MP0004142_abnormal_muscle_tone | 0.62090666 |
| 168 | MP0000627_abnormal_mammary_gland | 0.61319702 |
| 169 | MP0005165_increased_susceptibility_to | 0.61221036 |
| 170 | MP0003943_abnormal_hepatobiliary_system | 0.60996367 |
| 171 | MP0001348_abnormal_lacrimal_gland | 0.60522165 |
| 172 | MP0003011_delayed_dark_adaptation | 0.59857261 |
| 173 | MP0000733_abnormal_muscle_development | 0.57115281 |
| 174 | MP0001216_abnormal_epidermal_layer | 0.56915827 |
| 175 | MP0004233_abnormal_muscle_weight | 0.55913451 |
| 176 | MP0009278_abnormal_bone_marrow | 0.55662608 |
| 177 | * MP0003953_abnormal_hormone_level | 0.55305002 |
| 178 | MP0002060_abnormal_skin_morphology | 0.54551778 |
| 179 | MP0005365_abnormal_bile_salt | 0.53983425 |
| 180 | * MP0000026_abnormal_inner_ear | 0.53305508 |
| 181 | MP0004134_abnormal_chest_morphology | 0.52658371 |
| 182 | MP0005451_abnormal_body_composition | 0.49443394 |
| 183 | * MP0003936_abnormal_reproductive_system | 0.48824753 |
| 184 | MP0003638_abnormal_response/metabolism_ | 0.46633731 |
| 185 | MP0000163_abnormal_cartilage_morphology | 0.46464974 |
| 186 | MP0004484_altered_response_of | 0.46221569 |
| 187 | MP0003795_abnormal_bone_structure | 0.45659344 |
| 188 | MP0001191_abnormal_skin_condition | 0.45158762 |
| 189 | MP0002108_abnormal_muscle_morphology | 0.44102695 |
| 190 | MP0005257_abnormal_intraocular_pressure | 0.43344843 |
| 191 | MP0005595_abnormal_vascular_smooth | 0.43197861 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Goiter (HP:0000853) | 8.35428536 |
| 2 | Reduced antithrombin III activity (HP:0001976) | 8.15712830 |
| 3 | * Thyroid-stimulating hormone excess (HP:0002925) | 7.59530353 |
| 4 | Increased circulating renin level (HP:0000848) | 7.57041060 |
| 5 | Type I transferrin isoform profile (HP:0003642) | 7.45792629 |
| 6 | Hyperactive renin-angiotensin system (HP:0000841) | 7.37992236 |
| 7 | Metabolic alkalosis (HP:0200114) | 6.48363746 |
| 8 | Hypokalemic alkalosis (HP:0001949) | 6.10344685 |
| 9 | Tetany (HP:0001281) | 5.68311744 |
| 10 | Hyperthyroidism (HP:0000836) | 5.64441756 |
| 11 | Polyuria (HP:0000103) | 5.55778008 |
| 12 | Pili torti (HP:0003777) | 5.47533528 |
| 13 | Abnormal number of erythroid precursors (HP:0012131) | 5.47120867 |
| 14 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.47027374 |
| 15 | Abnormality of chloride homeostasis (HP:0011422) | 5.46291011 |
| 16 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 5.24583582 |
| 17 | Abnormal protein N-linked glycosylation (HP:0012347) | 5.24583582 |
| 18 | Abnormal protein glycosylation (HP:0012346) | 5.24583582 |
| 19 | Abnormal glycosylation (HP:0012345) | 5.24583582 |
| 20 | Congenital sensorineural hearing impairment (HP:0008527) | 5.23842425 |
| 21 | * Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 5.22134864 |
| 22 | Hyperaldosteronism (HP:0000859) | 5.08773835 |
| 23 | Renal salt wasting (HP:0000127) | 4.87888774 |
| 24 | Polydipsia (HP:0001959) | 4.76029721 |
| 25 | Abnormal drinking behavior (HP:0030082) | 4.76029721 |
| 26 | Abnormal urine output (HP:0012590) | 4.58010477 |
| 27 | Small epiphyses (HP:0010585) | 4.44945814 |
| 28 | Abnormality of renal excretion (HP:0011036) | 4.29605201 |
| 29 | Abnormality of renin-angiotensin system (HP:0000847) | 4.20488154 |
| 30 | Reticulocytopenia (HP:0001896) | 4.18393380 |
| 31 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.75869647 |
| 32 | Hypercalciuria (HP:0002150) | 3.75596018 |
| 33 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.72897985 |
| 34 | Thyroid carcinoma (HP:0002890) | 3.54092886 |
| 35 | Focal segmental glomerulosclerosis (HP:0000097) | 3.51011871 |
| 36 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.42540172 |
| 37 | Severe visual impairment (HP:0001141) | 3.42364800 |
| 38 | Increased hepatocellular lipid droplets (HP:0006565) | 3.39190933 |
| 39 | Prolonged partial thromboplastin time (HP:0003645) | 3.37877275 |
| 40 | Hepatocellular necrosis (HP:0001404) | 3.36602216 |
| 41 | Thrombocytosis (HP:0001894) | 3.36489376 |
| 42 | Nonprogressive disorder (HP:0003680) | 3.33938583 |
| 43 | Abnormality of cochlea (HP:0000375) | 3.31617977 |
| 44 | Abnormal hair laboratory examination (HP:0003328) | 3.28764877 |
| 45 | Delayed epiphyseal ossification (HP:0002663) | 3.28480907 |
| 46 | Abnormality of magnesium homeostasis (HP:0004921) | 3.26136728 |
| 47 | Macrocytic anemia (HP:0001972) | 3.23937857 |
| 48 | Alkalosis (HP:0001948) | 3.20843059 |
| 49 | Ankle contracture (HP:0006466) | 3.20227995 |
| 50 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.19952633 |
| 51 | Pallor (HP:0000980) | 3.14011149 |
| 52 | Hyperuricemia (HP:0002149) | 3.12431068 |
| 53 | Increased purine levels (HP:0004368) | 3.12431068 |
| 54 | Renal Fanconi syndrome (HP:0001994) | 3.11078298 |
| 55 | Flat occiput (HP:0005469) | 3.08517859 |
| 56 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.07242601 |
| 57 | Aplastic anemia (HP:0001915) | 3.04609489 |
| 58 | Type 2 muscle fiber atrophy (HP:0003554) | 3.02373493 |
| 59 | Exertional dyspnea (HP:0002875) | 3.02143555 |
| 60 | Petechiae (HP:0000967) | 2.99908221 |
| 61 | Lipid accumulation in hepatocytes (HP:0006561) | 2.96154827 |
| 62 | Cortical visual impairment (HP:0100704) | 2.94938366 |
| 63 | Muscle fiber atrophy (HP:0100295) | 2.93938563 |
| 64 | 3-Methylglutaconic aciduria (HP:0003535) | 2.90019746 |
| 65 | IgM deficiency (HP:0002850) | 2.89249853 |
| 66 | Hepatic necrosis (HP:0002605) | 2.87834214 |
| 67 | Hypokalemia (HP:0002900) | 2.86815358 |
| 68 | Gout (HP:0001997) | 2.85438274 |
| 69 | * Hypothyroidism (HP:0000821) | 2.85185186 |
| 70 | Increased intramyocellular lipid droplets (HP:0012240) | 2.75888732 |
| 71 | Adrenal overactivity (HP:0002717) | 2.73643227 |
| 72 | Abnormality of purine metabolism (HP:0004352) | 2.71671134 |
| 73 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.71079664 |
| 74 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.71079664 |
| 75 | Glomerulosclerosis (HP:0000096) | 2.70602739 |
| 76 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.68164092 |
| 77 | Nephrocalcinosis (HP:0000121) | 2.63693416 |
| 78 | Cardiovascular calcification (HP:0011915) | 2.63641158 |
| 79 | Chronic otitis media (HP:0000389) | 2.59239277 |
| 80 | Vascular calcification (HP:0004934) | 2.57682155 |
| 81 | Lower limb hyperreflexia (HP:0002395) | 2.49233481 |
| 82 | Abnormality of potassium homeostasis (HP:0011042) | 2.48050381 |
| 83 | Renal tubular acidosis (HP:0001947) | 2.46911292 |
| 84 | Microcytic anemia (HP:0001935) | 2.46126519 |
| 85 | Hypomagnesemia (HP:0002917) | 2.43247804 |
| 86 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.43099538 |
| 87 | Myositis (HP:0100614) | 2.39889131 |
| 88 | Facial shape deformation (HP:0011334) | 2.39808028 |
| 89 | Potter facies (HP:0002009) | 2.39808028 |
| 90 | Microvesicular hepatic steatosis (HP:0001414) | 2.39351691 |
| 91 | Increased muscle lipid content (HP:0009058) | 2.38763917 |
| 92 | True hermaphroditism (HP:0010459) | 2.38337639 |
| 93 | Mitochondrial inheritance (HP:0001427) | 2.37684533 |
| 94 | Respiratory difficulties (HP:0002880) | 2.33197158 |
| 95 | Morphological abnormality of the inner ear (HP:0011390) | 2.32748590 |
| 96 | Irregular epiphyses (HP:0010582) | 2.27934262 |
| 97 | Mild short stature (HP:0003502) | 2.25410753 |
| 98 | * Coarse facial features (HP:0000280) | 2.21934852 |
| 99 | Prolonged bleeding time (HP:0003010) | 2.17515806 |
| 100 | Abnormality of the axillary hair (HP:0100134) | 2.15664129 |
| 101 | Abnormality of secondary sexual hair (HP:0009888) | 2.15664129 |
| 102 | Abnormality of sodium homeostasis (HP:0010931) | 2.15240645 |
| 103 | Attenuation of retinal blood vessels (HP:0007843) | 2.14725433 |
| 104 | Pancytopenia (HP:0001876) | 2.11756968 |
| 105 | Split foot (HP:0001839) | 2.10671845 |
| 106 | Abnormality of renal resorption (HP:0011038) | 2.09460617 |
| 107 | Mitral stenosis (HP:0001718) | 2.08223060 |
| 108 | Hyperparathyroidism (HP:0000843) | 2.07428656 |
| 109 | * Constipation (HP:0002019) | 2.06642343 |
| 110 | Increased CSF lactate (HP:0002490) | 2.03361082 |
| 111 | Increased serum lactate (HP:0002151) | 2.02678727 |
| 112 | Hyponatremia (HP:0002902) | 2.00824923 |
| 113 | Epiphyseal dysplasia (HP:0002656) | 1.97208046 |
| 114 | Abnormality of the prostate (HP:0008775) | 1.96433782 |
| 115 | Meningitis (HP:0001287) | 1.94531269 |
| 116 | Interstitial pulmonary disease (HP:0006530) | 1.91894327 |
| 117 | Thoracic kyphosis (HP:0002942) | 1.91405886 |
| 118 | Epistaxis (HP:0000421) | 1.90235103 |
| 119 | Abnormality of T cell physiology (HP:0011840) | 1.89555927 |
| 120 | Recurrent abscess formation (HP:0002722) | 1.89465089 |
| 121 | Tubular atrophy (HP:0000092) | 1.88611854 |
| 122 | Panhypogammaglobulinemia (HP:0003139) | 1.88109113 |
| 123 | * Hyperpituitarism (HP:0010514) | 1.85776595 |
| 124 | Acute lymphatic leukemia (HP:0006721) | 1.84805342 |
| 125 | Knee flexion contracture (HP:0006380) | 1.84639469 |
| 126 | Dehydration (HP:0001944) | 1.84218133 |
| 127 | B lymphocytopenia (HP:0010976) | 1.83240403 |
| 128 | Abnormality of B cell number (HP:0010975) | 1.83240403 |
| 129 | Abnormality of the dental pulp (HP:0006479) | 1.82576794 |
| 130 | Abnormal platelet function (HP:0011869) | 1.82554099 |
| 131 | Impaired platelet aggregation (HP:0003540) | 1.82554099 |
| 132 | Obstructive sleep apnea (HP:0002870) | 1.80393317 |
| 133 | Pendular nystagmus (HP:0012043) | 1.80301233 |
| 134 | Vacuolated lymphocytes (HP:0001922) | 1.79716461 |
| 135 | Hypoproteinemia (HP:0003075) | 1.79698062 |
| 136 | Ulnar bowing (HP:0003031) | 1.78914580 |
| 137 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.77702912 |
| 138 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.77702912 |
| 139 | Abnormality of glycolipid metabolism (HP:0010969) | 1.77702912 |
| 140 | Hyperacusis (HP:0010780) | 1.77622954 |
| 141 | Bronchomalacia (HP:0002780) | 1.77530059 |
| 142 | Abnormality of permanent molar morphology (HP:0011071) | 1.77039113 |
| 143 | Abnormality of the dental root (HP:0006486) | 1.77039113 |
| 144 | Taurodontia (HP:0000679) | 1.77039113 |
| 145 | Fibular aplasia (HP:0002990) | 1.76480878 |
| 146 | Abnormality of nucleobase metabolism (HP:0010932) | 1.75829737 |
| 147 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.74685138 |
| 148 | Abnormality of alanine metabolism (HP:0010916) | 1.74685138 |
| 149 | Hyperalaninemia (HP:0003348) | 1.74685138 |
| 150 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.74666035 |
| 151 | Progressive muscle weakness (HP:0003323) | 1.71785532 |
| 152 | Agammaglobulinemia (HP:0004432) | 1.71161232 |
| 153 | Recurrent bronchitis (HP:0002837) | 1.68414080 |
| 154 | Gonadal dysgenesis (HP:0000133) | 1.68234138 |
| 155 | Patchy hypopigmentation of hair (HP:0011365) | 1.67883964 |
| 156 | Acute myeloid leukemia (HP:0004808) | 1.66711953 |
| 157 | Hypotension (HP:0002615) | 1.66364237 |
| 158 | Proximal tubulopathy (HP:0000114) | 1.66233241 |
| 159 | Abnormality of molar (HP:0011077) | 1.64169524 |
| 160 | Abnormality of molar morphology (HP:0011070) | 1.64169524 |
| 161 | Exercise intolerance (HP:0003546) | 1.63641280 |
| 162 | Renal tubular dysfunction (HP:0000124) | 1.63348063 |
| 163 | Bowing of the arm (HP:0006488) | 1.63084813 |
| 164 | Bowed forearm bones (HP:0003956) | 1.63084813 |
| 165 | Dry hair (HP:0011359) | 1.62924806 |
| 166 | Hypoplasia of the radius (HP:0002984) | 1.61950685 |
| 167 | Aortic aneurysm (HP:0004942) | 1.61733321 |
| 168 | Broad face (HP:0000283) | 1.61022493 |
| 169 | Lactic acidosis (HP:0003128) | 1.60749775 |
| 170 | Hyperphosphaturia (HP:0003109) | 1.60658724 |
| 171 | Acute necrotizing encephalopathy (HP:0006965) | 1.60647815 |
| 172 | Pancreatic fibrosis (HP:0100732) | 1.60266651 |
| 173 | Erythema (HP:0010783) | 1.59651447 |
| 174 | Migraine (HP:0002076) | 1.56635548 |
| 175 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.55496205 |
| 176 | Neoplasm of the thyroid gland (HP:0100031) | 1.55441892 |
| 177 | Chondrocalcinosis (HP:0000934) | 1.55397338 |
| 178 | Neutropenia (HP:0001875) | 1.55000060 |
| 179 | Abnormal spermatogenesis (HP:0008669) | 1.54854995 |
| 180 | Natal tooth (HP:0000695) | 1.54573171 |
| 181 | Tracheal stenosis (HP:0002777) | 1.53821594 |
| 182 | Abnormality of Sharpey fibers (HP:0100685) | 1.52525134 |
| 183 | Abnormality of the nasal septum (HP:0000419) | 1.50595914 |
| 184 | Short nail (HP:0001799) | 1.49706290 |
| 185 | Nephritis (HP:0000123) | 1.46656391 |
| 186 | Stage 5 chronic kidney disease (HP:0003774) | 1.45805714 |
| 187 | Humeroradial synostosis (HP:0003041) | 1.41538410 |
| 188 | Synostosis involving the elbow (HP:0003938) | 1.41538410 |
| 189 | Glucose intolerance (HP:0000833) | 1.41031007 |
| 190 | Large eyes (HP:0001090) | 1.39850327 |
| 191 | Femoral bowing (HP:0002980) | 1.39358146 |
| 192 | Flattened epiphyses (HP:0003071) | 1.36663111 |
| 193 | Tubulointerstitial fibrosis (HP:0005576) | 1.35364795 |
| 194 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.35314108 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK3 | 6.07160005 |
| 2 | TRIB3 | 5.01495984 |
| 3 | MST1R | 4.79101055 |
| 4 | EPHA2 | 4.61694504 |
| 5 | AKT3 | 4.14648397 |
| 6 | NLK | 4.10903450 |
| 7 | EIF2AK3 | 3.38557675 |
| 8 | STK16 | 3.10020284 |
| 9 | MUSK | 2.66052149 |
| 10 | KIT | 2.49504697 |
| 11 | RIPK1 | 2.44769596 |
| 12 | NME2 | 2.31008902 |
| 13 | MKNK2 | 2.10266446 |
| 14 | WEE1 | 2.05738833 |
| 15 | MET | 2.02529336 |
| 16 | CDK19 | 2.00990461 |
| 17 | TNIK | 10.6807879 |
| 18 | ERN1 | 1.96939916 |
| 19 | WNK4 | 1.84574881 |
| 20 | TEC | 1.80581014 |
| 21 | MKNK1 | 1.70992765 |
| 22 | CAMKK2 | 1.68748201 |
| 23 | DAPK2 | 1.66648117 |
| 24 | PIM2 | 1.55148661 |
| 25 | TLK1 | 1.52444990 |
| 26 | SGK2 | 1.51516254 |
| 27 | MAP3K3 | 1.50949855 |
| 28 | FES | 1.50491241 |
| 29 | FLT3 | 1.49046757 |
| 30 | MAP3K2 | 1.39840199 |
| 31 | CDK12 | 1.39602108 |
| 32 | VRK1 | 1.35219571 |
| 33 | TRPM7 | 1.34762837 |
| 34 | SGK3 | 1.33739587 |
| 35 | EIF2AK2 | 1.31929047 |
| 36 | MELK | 1.31573322 |
| 37 | SIK1 | 1.31283320 |
| 38 | IRAK4 | 1.26585336 |
| 39 | LMTK2 | 1.23031298 |
| 40 | IRAK3 | 1.21020847 |
| 41 | SGK494 | 1.20967764 |
| 42 | SGK223 | 1.20967764 |
| 43 | CASK | 1.20629221 |
| 44 | MAP3K7 | 1.20203985 |
| 45 | NTRK1 | 1.17265775 |
| 46 | BTK | 1.16992095 |
| 47 | LATS1 | 1.15026873 |
| 48 | DYRK3 | 1.14964070 |
| 49 | MATK | 1.13845227 |
| 50 | CAMK1 | 1.13288654 |
| 51 | CLK1 | 1.13150670 |
| 52 | PTK2 | 1.12135918 |
| 53 | MAP2K7 | 1.08881181 |
| 54 | PDPK1 | 1.08595918 |
| 55 | RET | 1.07722305 |
| 56 | TIE1 | 1.03692359 |
| 57 | BUB1 | 1.02611943 |
| 58 | YES1 | 1.01172339 |
| 59 | ILK | 1.00767621 |
| 60 | BRSK2 | 0.99538581 |
| 61 | CDC42BPA | 0.97747668 |
| 62 | CSF1R | 0.96475165 |
| 63 | TGFBR1 | 0.95892314 |
| 64 | STK38 | 0.95484848 |
| 65 | MARK2 | 0.95450479 |
| 66 | TGFBR2 | 0.94631110 |
| 67 | RPS6KA2 | 0.94565895 |
| 68 | DMPK | 0.94161733 |
| 69 | TTN | 0.93959826 |
| 70 | ACVR1B | 0.93877221 |
| 71 | MTOR | 0.93488834 |
| 72 | STK39 | 0.91882365 |
| 73 | SRPK1 | 0.89480606 |
| 74 | BLK | 0.88080751 |
| 75 | MAP3K12 | 0.86573719 |
| 76 | MAPKAPK5 | 0.84567617 |
| 77 | PDGFRA | 0.83244853 |
| 78 | BMX | 0.82734066 |
| 79 | EPHA3 | 0.81380822 |
| 80 | ADRBK2 | 0.79737466 |
| 81 | MAPK4 | 0.77323507 |
| 82 | EIF2AK1 | 0.76377889 |
| 83 | PDK1 | 0.71804557 |
| 84 | FGFR4 | 0.70493908 |
| 85 | EPHB1 | 0.69921130 |
| 86 | ABL2 | 0.69853988 |
| 87 | EPHB2 | 0.69831047 |
| 88 | MAP4K1 | 0.69684289 |
| 89 | JAK1 | 0.67983245 |
| 90 | PAK2 | 0.67765883 |
| 91 | MST4 | 0.64633284 |
| 92 | SMG1 | 0.64334862 |
| 93 | CHUK | 0.64040074 |
| 94 | TXK | 0.63262326 |
| 95 | LYN | 0.63094597 |
| 96 | KDR | 0.61920654 |
| 97 | CDK7 | 0.58382965 |
| 98 | SYK | 0.58142740 |
| 99 | MAP2K2 | 0.56843123 |
| 100 | TBK1 | 0.55806655 |
| 101 | PDGFRB | 0.55336431 |
| 102 | RIPK4 | 0.55172435 |
| 103 | FER | 0.54488197 |
| 104 | BCKDK | 0.54454392 |
| 105 | PRKG2 | 0.54194107 |
| 106 | MAPKAPK2 | 0.53197759 |
| 107 | ZAP70 | 0.53093314 |
| 108 | PTK6 | 0.52848345 |
| 109 | IKBKE | 0.51238556 |
| 110 | RPS6KL1 | 0.50484418 |
| 111 | RPS6KC1 | 0.50484418 |
| 112 | STK24 | 0.50248873 |
| 113 | LATS2 | 0.50227054 |
| 114 | IKBKB | 0.50138739 |
| 115 | PRKD2 | 0.47449976 |
| 116 | TESK1 | 0.46729694 |
| 117 | RPS6KA6 | 0.46596378 |
| 118 | CDK8 | 0.46541735 |
| 119 | GSK3A | 0.46119792 |
| 120 | IRAK2 | 0.44876608 |
| 121 | LCK | 0.44672805 |
| 122 | TYK2 | 0.44051413 |
| 123 | PKN1 | 0.43041800 |
| 124 | MAPK13 | 0.43005441 |
| 125 | ERBB2 | 0.41565570 |
| 126 | FGFR3 | 0.41539531 |
| 127 | MAPK15 | 0.40954278 |
| 128 | IRAK1 | 0.40553860 |
| 129 | MYLK | 0.39831076 |
| 130 | CCNB1 | 0.39761934 |
| 131 | BMPR1B | 0.39288576 |
| 132 | PIM1 | 0.38326933 |
| 133 | PAK4 | 0.37318137 |
| 134 | CSNK1A1 | 0.37136905 |
| 135 | MAP2K3 | 0.36903693 |
| 136 | EPHA4 | 0.35926189 |
| 137 | JAK3 | 0.35322388 |
| 138 | STK38L | 0.35245252 |
| 139 | OXSR1 | 0.34751055 |
| 140 | MAP3K6 | 0.34695700 |
| 141 | GRK7 | 0.34562765 |
| 142 | AKT2 | 0.34102332 |
| 143 | RPS6KB2 | 0.33796970 |
| 144 | PRKD1 | 0.33475638 |
| 145 | MAP3K11 | 0.32152500 |
| 146 | ROCK1 | 0.31768197 |
| 147 | HIPK2 | 0.31344166 |
| 148 | MAPKAPK3 | 0.30972798 |
| 149 | FGFR2 | 0.29694913 |
| 150 | TAOK3 | 0.29339808 |
| 151 | PRKAA2 | 0.29310144 |
| 152 | PLK4 | 0.27951017 |
| 153 | NEK2 | 0.27808495 |
| 154 | CSNK2A2 | 0.27547175 |
| 155 | CSNK1G1 | 0.27320846 |
| 156 | CSNK2A1 | 0.26978151 |
| 157 | ICK | 0.26066083 |
| 158 | NEK6 | 0.25415901 |
| 159 | PDK2 | 0.24828559 |
| 160 | RAF1 | 0.24613950 |
| 161 | CDK4 | 0.23982273 |
| 162 | CSNK1G3 | 0.22504892 |
| 163 | DYRK2 | 0.22465840 |
| 164 | CDK9 | 0.22093606 |
| 165 | MAPK1 | 0.22072551 |
| 166 | DAPK3 | 0.21463286 |
| 167 | SGK1 | 0.20868236 |
| 168 | DYRK1B | 0.20535881 |
| 169 | PINK1 | 0.19776153 |
| 170 | MAP2K6 | 0.18240338 |
| 171 | PIK3CG | 0.17264986 |
| 172 | CDK3 | 0.16695583 |
| 173 | MAPK11 | 0.16198887 |
| 174 | SCYL2 | 0.16195002 |
| 175 | MAP3K14 | 0.15422342 |
| 176 | RPS6KA4 | 0.14251086 |
| 177 | ABL1 | 0.12751324 |
| 178 | CSK | 0.11729885 |
| 179 | MAP3K1 | 0.11507337 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Thyroid hormone synthesis_Homo sapiens_hsa04918 | 5.70280054 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 5.59128432 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 4.67237503 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.51779443 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.74423651 |
| 6 | Homologous recombination_Homo sapiens_hsa03440 | 2.62570444 |
| 7 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.61319604 |
| 8 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.53833308 |
| 9 | RNA polymerase_Homo sapiens_hsa03020 | 2.44354274 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.43582085 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.41537708 |
| 12 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.40433486 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.37540867 |
| 14 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.18899040 |
| 15 | Spliceosome_Homo sapiens_hsa03040 | 2.15420624 |
| 16 | Bladder cancer_Homo sapiens_hsa05219 | 2.05283226 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.96433284 |
| 18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.90744612 |
| 19 | Sulfur relay system_Homo sapiens_hsa04122 | 1.84483128 |
| 20 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.84310819 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.82253351 |
| 22 | Focal adhesion_Homo sapiens_hsa04510 | 1.72152281 |
| 23 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.70997165 |
| 24 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.69546274 |
| 25 | Proteasome_Homo sapiens_hsa03050 | 1.69315981 |
| 26 | Hepatitis C_Homo sapiens_hsa05160 | 1.65702092 |
| 27 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.64340775 |
| 28 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.64295286 |
| 29 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.48605163 |
| 30 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.48004599 |
| 31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.46756582 |
| 32 | * Thyroid cancer_Homo sapiens_hsa05216 | 1.46043482 |
| 33 | Tight junction_Homo sapiens_hsa04530 | 1.41672217 |
| 34 | Purine metabolism_Homo sapiens_hsa00230 | 1.40278552 |
| 35 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.40255812 |
| 36 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.39985391 |
| 37 | Circadian rhythm_Homo sapiens_hsa04710 | 1.35202396 |
| 38 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.33724598 |
| 39 | Adherens junction_Homo sapiens_hsa04520 | 1.33492686 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.31682465 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.29955603 |
| 42 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.29450799 |
| 43 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.29095529 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.27173507 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.24839081 |
| 46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.23489833 |
| 47 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.21070027 |
| 48 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.18686999 |
| 49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.16307888 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16043506 |
| 51 | Basal transcription factors_Homo sapiens_hsa03022 | 1.15027482 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14143993 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 1.13008497 |
| 54 | Lysosome_Homo sapiens_hsa04142 | 1.12388394 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12256221 |
| 56 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.10380634 |
| 57 | Measles_Homo sapiens_hsa05162 | 1.07692035 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.01875971 |
| 59 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.01530873 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.01069161 |
| 61 | Parkinsons disease_Homo sapiens_hsa05012 | 1.00565192 |
| 62 | Prostate cancer_Homo sapiens_hsa05215 | 0.97959083 |
| 63 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.96308259 |
| 64 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.96046037 |
| 65 | Melanoma_Homo sapiens_hsa05218 | 0.95311393 |
| 66 | Galactose metabolism_Homo sapiens_hsa00052 | 0.94887315 |
| 67 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.93885224 |
| 68 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.93791999 |
| 69 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.93178953 |
| 70 | RNA degradation_Homo sapiens_hsa03018 | 0.92226384 |
| 71 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.91711662 |
| 72 | Allograft rejection_Homo sapiens_hsa05330 | 0.90951753 |
| 73 | Leishmaniasis_Homo sapiens_hsa05140 | 0.90702956 |
| 74 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.90517664 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.89950968 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.88239560 |
| 77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87851350 |
| 78 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85375808 |
| 79 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.84512145 |
| 80 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.83901095 |
| 81 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.83001535 |
| 82 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.82803581 |
| 83 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.82397657 |
| 84 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.81447406 |
| 85 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.77664459 |
| 86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77160804 |
| 87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.76654745 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.75977005 |
| 89 | Asthma_Homo sapiens_hsa05310 | 0.75222044 |
| 90 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.74797503 |
| 91 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.73982371 |
| 92 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73366681 |
| 93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.72540844 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72057182 |
| 95 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70556220 |
| 96 | Lysine degradation_Homo sapiens_hsa00310 | 0.70129428 |
| 97 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.69829621 |
| 98 | Cell cycle_Homo sapiens_hsa04110 | 0.69027847 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.68211456 |
| 100 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.68178798 |
| 101 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.68159536 |
| 102 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.67995071 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.67726611 |
| 104 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.67553063 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.66695149 |
| 106 | Malaria_Homo sapiens_hsa05144 | 0.66145567 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65370181 |
| 108 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.65339823 |
| 109 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.64947095 |
| 110 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63692447 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.63293136 |
| 112 | Huntingtons disease_Homo sapiens_hsa05016 | 0.62234481 |
| 113 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.61620404 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61213958 |
| 115 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60943468 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60925141 |
| 117 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.60552785 |
| 118 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.60205503 |
| 119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58597714 |
| 120 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58531807 |
| 121 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56018126 |
| 122 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.55327045 |
| 123 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.54253938 |
| 124 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.53511527 |
| 125 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.53296742 |
| 126 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.53258441 |
| 127 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.53245390 |
| 128 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53202156 |
| 129 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.52919200 |
| 130 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52776670 |
| 131 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.52111531 |
| 132 | Pertussis_Homo sapiens_hsa05133 | 0.52037019 |
| 133 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51537667 |
| 134 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.50751035 |
| 135 | Alzheimers disease_Homo sapiens_hsa05010 | 0.50170151 |
| 136 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49580371 |
| 137 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49333252 |
| 138 | Apoptosis_Homo sapiens_hsa04210 | 0.48532598 |
| 139 | RNA transport_Homo sapiens_hsa03013 | 0.46004809 |
| 140 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.45432560 |
| 141 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.45040642 |
| 142 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.44999264 |
| 143 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.43936519 |
| 144 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.43797212 |
| 145 | Salmonella infection_Homo sapiens_hsa05132 | 0.43597509 |
| 146 | Endocytosis_Homo sapiens_hsa04144 | 0.40879409 |
| 147 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40332050 |
| 148 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39485861 |
| 149 | Influenza A_Homo sapiens_hsa05164 | 0.39180711 |
| 150 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38373923 |
| 151 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37756314 |
| 152 | Mineral absorption_Homo sapiens_hsa04978 | 0.37468578 |
| 153 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.36436850 |
| 154 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.36415528 |
| 155 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34774074 |
| 156 | Shigellosis_Homo sapiens_hsa05131 | 0.34717924 |
| 157 | Salivary secretion_Homo sapiens_hsa04970 | 0.34619845 |
| 158 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.34418929 |
| 159 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.32347361 |
| 160 | Colorectal cancer_Homo sapiens_hsa05210 | 0.32139049 |
| 161 | Hepatitis B_Homo sapiens_hsa05161 | 0.30558485 |
| 162 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.30516845 |
| 163 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29895729 |
| 164 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.29148248 |
| 165 | ABC transporters_Homo sapiens_hsa02010 | 0.28297242 |
| 166 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.28261742 |
| 167 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.28052151 |
| 168 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.27379805 |
| 169 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.27016389 |
| 170 | Legionellosis_Homo sapiens_hsa05134 | 0.26153195 |
| 171 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.23945383 |
| 172 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.23793383 |
| 173 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.21600177 |
| 174 | Histidine metabolism_Homo sapiens_hsa00340 | 0.21304568 |
| 175 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.20525389 |
| 176 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.19231249 |
| 177 | Tuberculosis_Homo sapiens_hsa05152 | 0.19134788 |

